These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30709946)

  • 1. OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On.
    Bruyn GA; Iagnocco A; Naredo E; Balint PV; Gutierrez M; Hammer HB; Collado P; Filippou G; Schmidt WA; Jousse-Joulin S; Mandl P; Conaghan PG; Wakefield RJ; Keen HI; Terslev L; D'Agostino MA;
    J Rheumatol; 2019 Oct; 46(10):1388-1393. PubMed ID: 30709946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example.
    Terslev L; Naredo E; Keen HI; Bruyn GAW; Iagnocco A; Wakefield RJ; Conaghan PG; Maxwell LJ; Beaton DE; Boers M; D'Agostino MA
    J Rheumatol; 2019 Oct; 46(10):1394-1400. PubMed ID: 30877208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.
    Chiarotto A; Kaiser U; Choy E; Christensen R; Conaghan PG; Cowern M; Gill M; de Wit M; Gargon E; Horgan B; Kirkham JJ; Simon LS; Singh JA; Tugwell P; Turk DC; Mease PJ
    J Rheumatol; 2019 Oct; 46(10):1355-1359. PubMed ID: 30936284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
    Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.
    Maxwell LJ; Beaton DE; Boers M; D'Agostino MA; Conaghan PG; Grosskleg S; Shea BJ; Bingham Iii CO; Boonen A; Christensen R; Choy E; Doria AS; Hill CL; Hofstetter C; Kroon FP; Leung YY; Mackie S; Meara A; Touma Z; Tugwell P; Wells GA
    Semin Arthritis Rheum; 2021 Dec; 51(6):1320-1330. PubMed ID: 34544617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    Wong PC; Lee G; Delle Sedie A; Hanova P; Inanc N; Jousse-Joulin S; Ohrndorf S; Stoenoiu MS; Keen HI; Terslev L; D'Agostino MA; Bruyn GA
    J Rheumatol; 2019 Oct; 46(10):1379-1387. PubMed ID: 31203213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the OMERACT filter: implications for imaging and soluble biomarkers.
    D'Agostino MA; Boers M; Kirwan J; van der Heijde D; Østergaard M; Schett G; Landewé RB; Maksymowych WP; Naredo E; Dougados M; Iagnocco A; Bingham CO; Brooks PM; Beaton DE; Gandjbakhch F; Gossec L; Guillemin F; Hewlett SE; Kloppenburg M; March L; Mease PJ; Moller I; Simon LS; Singh JA; Strand V; Wakefield RJ; Wells GA; Tugwell P; Conaghan PG
    J Rheumatol; 2014 May; 41(5):1016-24. PubMed ID: 24584916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
    Toupin-April K; Barton JL; Fraenkel L; Meara A; Li LC; Brooks P; de Wit M; Stacey D; Légaré F; Shea B; Lyddiatt A; Hofstetter C; Christensen R; Scholte Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Karuranga S; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Beaton D; El-Miedany Y; Mittoo S; Bartlett SJ; Singh JA; Tugwell PS
    J Rheumatol; 2019 Oct; 46(10):1409-1414. PubMed ID: 30709963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.
    Boers M; Beaton DE; Shea BJ; Maxwell LJ; Bartlett SJ; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March L; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1021-1027. PubMed ID: 30770515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OMERACT: an international initiative to improve outcome measurement in rheumatology.
    Boers M; Brooks P; Simon LS; Strand V; Tugwell P
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S10-3. PubMed ID: 16273779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018.
    Craig ET; Orbai AM; Mackie S; Bartlett SJ; Bingham CO; Goodman S; Hill C; Holt R; Leong A; Karyekar C; Leung YY; Richards P; Halls S
    J Rheumatol; 2019 Oct; 46(10):1374-1378. PubMed ID: 30770511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12.
    Bruyn GA; Naredo E; Iagnocco A; Balint PV; Backhaus M; Gandjbakhch F; Gutierrez M; Filer A; Finzel S; Ikeda K; Kaeley GS; Manzoni SM; Ohrndorf S; Pineda C; Richards B; Roth J; Schmidt WA; Terslev L; D'Agostino MA;
    J Rheumatol; 2015 Nov; 42(11):2172-6. PubMed ID: 25774059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.
    Tugwell P; Boers M; D'Agostino MA; Beaton D; Boonen A; Bingham CO; Choy E; Conaghan PG; Dougados M; Duarte C; Furst DE; Guillemin F; Gossec L; Heiberg T; van der Heijde DM; Hewlett S; Kirwan JR; Kvien TK; Landewé RB; Mease PJ; Østergaard M; Simon L; Singh JA; Strand V; Wells G
    J Rheumatol; 2014 May; 41(5):1000-4. PubMed ID: 24692531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updating the OMERACT filter: core areas as a basis for defining core outcome sets.
    Kirwan JR; Boers M; Hewlett S; Beaton D; Bingham CO; Choy E; Conaghan PG; D'Agostino MA; Dougados M; Furst DE; Guillemin F; Gossec L; van der Heijde DM; Kloppenburg M; Kvien TK; Landewé RB; Mackie SL; Matteson EL; Mease PJ; Merkel PA; Ostergaard M; Saketkoo LA; Simon L; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2014 May; 41(5):994-9. PubMed ID: 24634204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.
    Beaton DE; Maxwell LJ; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1028-1035. PubMed ID: 30709952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level.
    Sirotti S; Terslev L; Filippucci E; Iagnocco A; Moller I; Naredo E; Vreju FA; Adinolfi A; Becce F; Hammer HB; Cazenave T; Cipolletta E; Christiansen SN; Delle Sedie A; Diaz M; Figus F; Mandl P; MacCarter D; Mortada MA; Mouterde G; Porta F; Reginato AM; Schmidt WA; Serban T; Wakefield RJ; Zufferey P; Sarzi-Puttini P; Zanetti A; Damiani A; Pineda C; Keen HI; D'Agostino MA; Filippou G;
    Lancet Rheumatol; 2023 Aug; 5(8):e474-e482. PubMed ID: 38251579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.